ストックスクリーナーアプリを入手
3.94
10.67%
0.38
アフターアワーズ：
3.94
前日終値:
$3.56
開ける：
$3.75
24時間の取引高:
175.48K
Relative Volume:
1.82
時価総額：
$34.29M
収益：
-
当期純損益:
$-4.69M
株価収益率:
-1.691
EPS:
-2.33
ネットキャッシュフロー:
$-3.81M
1週間 パフォーマンス:
+0.25%
1か月 パフォーマンス:
-2.72%
6か月 パフォーマンス:
+75.89%
1年 パフォーマンス:
+64.14%
1日の値動き範囲:
$3.6299
$4.0326
1週間の範囲:
$3.50
$4.0326
52週間の値動き範囲:
$0.64
$6.26
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
名前
Lixte Biotechnology Holdings Inc
セクター
電話
310 203 2902
住所
433 PLAZA REAL, BOCA RATON
LIXT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
3.94 | 30.98M | 0 | -4.69M | -3.81M | -2.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lixte Biotechnology Holdings Inc (LIXT) 最新ニュース
Will Lixte Biotechnology Holdings Inc. (8640) stock deliver compounding returns2026 world cup usa national team quarterfinals young talents transition play winner prediction breakdown - ulpravda.ru
Aug Decliners: Why Lixte Biotechnology Holdings Inc. (8640) stock is listed among top recommendationsInsider Buying & Weekly Momentum Stock Picks - moha.gov.vn
What analysts say about Lixte Biotechnology Holdings Inc 8640 stockCandlestick Trading Patterns & High Return Stock Picks - earlytimes.in
What analysts say about SBCWW stockTechnical Breakout Signals & Free Wealth Planning Blueprints - earlytimes.in
Should You Add Aster DM Healthcare Limited Stock to Your Portfolio NowResistance Breakout Alerts & Minimal Capital Growth - earlytimes.in
Is Lixte Biotechnology Holdings Inc. stock trading at a premium valuationAnalyst Upgrades & Free High Yield Investment Strategies - bollywoodhelpline.com
Lixte Simplifies Capital Structure via Share Exchange Deal - TipRanks
Price Clustering Detected in Anupam Finserv Limited StockLong-Term Investment Plans & Low Risk High Yield - bollywoodhelpline.com
Will Lixte Biotechnology Holdings Inc. stock see insider buyingTake Profit Strategies & Low Entry Investment Portfolio - Bollywood Helpline
LIXTE expands clinical trial for ovarian cancer treatment By Investing.com - Investing.com Australia
Lixte Expands LB-100 Ovarian Cancer Trial Collaboration - TipRanks
Lixte expands LB-100 ovarian cancer trial collaboration - MSN
Key facts: Lixte Biotechnology secures $4.3M funding; expands cancer collaboration - TradingView — Track All Markets
LIXTE expands clinical trial for ovarian cancer treatment - Investing.com India
Lixte Biotechnology Holdings expands collaboration with University of Texas MD Anderson Cancer Center & GSK for LB-100 - marketscreener.com
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial - InvestorNews
Experimental ovarian cancer trial doubles the number of patients it will enroll - Stock Titan
Spartan Capital acts as placement agent in Lixte’s $4.3 million offering - Investing.com Nigeria
Lixte Biotechnology Announces New Registered Direct Offering - TipRanks
Lixte Biotechnology Signs Multiple Material Agreements - TradingView — Track All Markets
Spartan Capital acts as placement agent in Lixte’s $4.3 million offering By Investing.com - Investing.com South Africa
Lixte Biotechnology stock falls after $4.3 million direct offering - Investing.com
Lixte Biotechnology stock falls after $4.3 million direct offering By Investing.com - Investing.com Canada
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $4.3 Million Registered Direct Offering - The Manila Times
Will Lixte Biotechnology Holdings Inc. stock keep outperforming rivalsJuly 2025 Setups & Advanced Technical Signal Analysis - Улправда
Whale Trades: Is Lixte Biotechnology Holdings Inc. Equity Warrant stock a contrarian buyMarket Growth Report & Entry and Exit Point Strategies - Улправда
Profit Recap: What sentiment indicators say about Lixte Biotechnology Holdings Inc stockJuly 2025 Big Picture & Weekly Consistent Profit Watchlists - moha.gov.vn
Momentum Shift: Is Lixte Biotechnology Holdings Inc. stock trading at a premium valuation2025 Analyst Calls & Fast Entry Momentum Trade Alerts - Улправда
Can Lixte Biotechnology Holdings Inc. Equity Warrant stock deliver consistent earnings growthPortfolio Gains Report & Fast Momentum Entry Tips - Улправда
What Wall Street predicts for Lixte Biotechnology Holdings Inc. Equity Warrant stock pricePortfolio Return Report & Daily Profit Maximizing Trade Tips - Улправда
Is Lixte Biotechnology Holdings Inc. Equity Warrant stock a contrarian buyTrade Risk Summary & Weekly Market Pulse Alerts - Улправда
Is Lixte Biotechnology Holdings Inc. stock a buy before product launchesInsider Buying & Expert Approved Trade Ideas - Улправда
Can Lixte Biotechnology Holdings Inc. stock continue upward trendPortfolio Update Summary & Real-Time Volume Triggers - ulpravda.ru
Will Lixte Biotechnology Holdings Inc. stock outperform tech sector in 2025Share Buyback & Stepwise Trade Execution Plans - Улправда
Why Lixte Biotechnology Holdings Inc. stock is a value investor pickJuly 2025 Trade Ideas & Scalable Portfolio Growth Ideas - DonanımHaber
Is Lixte Biotechnology Holdings Inc. Equity Warrant stock attractive for hedge funds2025 Technical Overview & Community Verified Watchlist Alerts - Улправда
Is Lixte Biotechnology Holdings Inc. (8640) stock nearing a technical breakoutQuarterly Profit Summary & Advanced Swing Trade Entry Alerts - DonanımHaber
What dividend safety rating applies to Lixte Biotechnology Holdings Inc. (8640) stockWeekly Trend Recap & AI Forecasted Entry/Exit Points - DonanımHaber
Will Lixte Biotechnology Holdings Inc. stock split again soon2025 Geopolitical Influence & Advanced Technical Signal Analysis - Улправда
Lixte Biotechnology shares dip after $4.3 million registered direct offering - MSN
Why Lixte Biotechnology Holdings Inc. (8640) stock is listed among top recommendationsMarket Activity Recap & Real-Time Volume Spike Alerts - Улправда
Lixte Biotechnology raises $4.3 million in registered direct offering By Investing.com - Investing.com India
Aug Sentiment: Is Lixte Biotechnology Holdings Inc. stock a buy before product launchesPortfolio Profit Report & Weekly High Potential Alerts - Улправда
Insider Trends: Will Lixte Biotechnology Holdings Inc. stock see insider buyingJuly 2025 Short Interest & Trade Opportunity Analysis Reports - Улправда
Lixte Biotechnology Launches $4.3 Million Registered Direct Offering - marketscreener.com
History Review: Will Lixte Biotechnology Holdings Inc. stock see insider buyingGap Up & Reliable Volume Spike Alerts - Улправда
Lixte Biotechnology prices $4.3M registered direct offering - MSN
Lixte Biotechnology Holdings Inc (LIXT) 財務データ
収益
当期純利益
現金流量
EPS
28.63%
大文字化:
|
ボリューム (24 時間):